Chi‐Cheng Li
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Immunology 51
- T-cell and B-cell Immunology 47
- Immune Cell Function and Interaction 47
- Immunotherapy and Immune Responses 38
- Co-authors
- Jih‐Luh Tang (16 shared papers)Hwei‐Fang Tien (15 shared papers)Ming Yao (14 shared papers)Py‐Yu Lin (47 shared papers)Kuo‐Liang Yang (48 shared papers)Yao‐Chang Chen (4 shared papers)Ih‐Jen Su (1 shared paper)Ruey‐Long Hong (1 shared paper)
- Journals
- HLA (46 papers)Blood (4 papers)Environmental Toxicology (3 papers)Journal of Cellular Biochemistry (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- TaiwanUnited StatesIndia
In The Last Decade
Chi‐Cheng Li
95 papers receiving 726 citations
Peers
Comparison fields: 5 of 79
- Hematology 135
- Pathology and Forensic Medicine 163
- Immunology 162
- Transplantation 19
- Health Informatics 9
Countries citing papers authored by Chi‐Cheng Li
This map shows the geographic impact of Chi‐Cheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Cheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Cheng Li more than expected).
Fields of papers citing papers by Chi‐Cheng Li
This network shows the impact of papers produced by Chi‐Cheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Cheng Li. The network helps show where Chi‐Cheng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Cheng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 141 | |
| 2 | 2018 | 73 | |
| 3 | 2019 | 44 | |
| 4 | 2015 | 41 | |
| 5 | 2018 | 36 | |
| 6 | 2020 | 27 | |
| 7 | 2018 | 25 | |
| 8 | 2016 | 25 | |
| 9 | 2021 | 16 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 14 | |
| 12 | 2002 | 13 | |
| 13 | Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma. | 2004 | 12 |
| 14 | 2008 | 12 | |
| 15 | 2022 | 11 | |
| 16 | 2019 | 9 | |
| 17 | 2014 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 8 |
About Chi‐Cheng Li
Chi‐Cheng Li is a scholar working on Immunology, Molecular Biology, Hematology, Oncology and Cancer Research, having authored 100 papers that have together received 729 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (47 papers), Immune Cell Function and Interaction (47 papers), Immunotherapy and Immune Responses (38 papers), Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer-related molecular mechanisms research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (135 citations), Pathology and Forensic Medicine (163 citations), Immunology (162 citations), Transplantation (19 citations) and Health Informatics (9 citations). Chi‐Cheng Li has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Jih‐Luh Tang, Hwei‐Fang Tien, Ming Yao, Py‐Yu Lin, Kuo‐Liang Yang, Yao‐Chang Chen, Ih‐Jen Su, Ruey‐Long Hong, Su‐Ming Hsu and Bor‐Sheng Ko. Their work appears in journals such as HLA, Blood, Environmental Toxicology, Journal of Cellular Biochemistry and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.